PL
Pluri Inc.
PLUR · NASDAQ
$1.08 +0.00% (+$0.00)
1M -30.77%
Market Cap $11.7M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$1.26
16.7% upside
Current Price
$1.08
Undervalued Fair Value Overvalued
According to Bulios Fair Price, PLUR is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 11.47x
PEG N/A
P/E N/A
Growth
100 /100
Growing Rev. growth 52.41%
Book val. growth N/A
EPS growth N/A
Profitability
18 /100
Weak Op. margin 2,455.91%
Gross margin 44.59%
FCF margin 1,990.26%
Quality
58 /100
Average Asset turnover 0.04x
ROIC 364.29%
ROA 98.26%
Debt
0 /100
High Int. coverage -26.30x
Current ratio 0.27x
Debt/Assets N/A
Stability
56 /100
Moderate EPS volatility 13.24%
Beta 0.67x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PLUR
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Yaacov Yanay
Employees
92
Headquarters
Haifa
Upcoming events
05 NOV
Earnings
Upcoming earnings report